Clinical Trial Update: Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study [NA]

View source ↗

Summary

A feasibility study evaluating CLEARPEMSONIC for characterizing breast lesions in breast cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Breast Carcinoma | NA | Status: TERMINATED